Protagonist Therapeutics: Q4 Earnings Snapshot
By AP News
Published - Mar 15, 2023, 04:19 PM ET
Last Updated - Jun 22, 2023, 04:02 PM EDT
NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $34.2 million in its fourth quarter.
On a per-share basis, the Newark, California-based company said it had a loss of 69 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.
For the year, the company reported a loss of $127.4 million, or $2.60 per share. Revenue was reported as $26.6 million.
